[1] Herszényi L,Tulassay Z. Epidemiology of gastrointestinal and liver tumors[J]. Eur Rev Med Pharmacol Sci,2010,14(4):249-258.
[2] 吴岩,贺宇彤. 食管癌病因学[J]. 食管外科电子杂志,2014, 2(3):114-120.
[3] 赫捷,邵康. 中国食管癌流行病学现状,诊疗现状及未来对策[J]. 中国癌症杂志,2011,21(7):501-504.
[4] Henry MA,Lerco MM,Ribeiro PW,et al. Epidemiological features of esophageal cancer:Squamous cell carcinoma versus adenocarcinoma[J]. Acta Cir Bras,2014,29(6):389-393.
[5] Kanojia D,Vaidya MM. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis[J]. Oral Oncol,2006,42(7):655-667.
[6] Imaida K,Sato H,Okamiya H,et al. Enhancing effect of high fat diet on 4-nitroquinoline 1-oxide-induced pulmonary tumorigenesis in ICR male mice[J]. Jpn J Cancer Res,1989,80(6):499-502.
[7] Shrotriya S,Tyagi A,Deep G,et al. Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses[J]. Mol Carcinog, 2015,54(4):291-300.
[8] Chen Y,Jiang Y,Liao L,et al. Inhibition of 4NQO-induced oral carcinogenesis by dietary oyster shell calcium[J]. Integr Cancer Ther,2015. doi:10.1177/1534735415596572.
[9] Jiang Y,Liao L,Shrestha C,et al. Inhibition of 4-nitroquinoline-1-oxide-induced oral carcinogenesis by dietary calcium[J]. Int J Clin Exp Pathol,2015,8(4):3529-3542.
[10] Enson AM. Conversion of 4-nitroquinoline-1-oxide(4NQO) to 4-hydroxyamino-quinoline-1-oxide by a dicumarol-resistant hepatic 4NQO introreductase in rats and mice[J]. Biochem Pharmacol, 1993,46(7):1217-1221.
[11] Brüsehafer K,Manshian BB,Doherty AT,et al. The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity,length of exposure and p53 proficiency[J]. Mutagenesis,2015. doi:10.1093/mutage/gev069.
[12] Waters R,Jones CJ,Martin EA,et al. The repair of large DNA adducts in mammalian cells[J]. Mutat Res,1992,273(2):145-155.
[13] Urvalek AM,Osei-Sarfo K,Tang XH,et al. Identification of ethanol and 4-nitroquinoline-1-oxide induced epigenetic and oxidative stress markers during oral cavity carcinogenesis[J]. Alcohol Clin Exp Res,2015,39(8):1360-1372.
[14] Morrow CS,Diah S,Smitherman PK,et al. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline-1-oxide toxicity[J]. Carcinogenesis, 1998,19(1):109-115.
[15] de Visscher SA,Witjes MJ,vander Vegt B,et al. Localization of liposomal mTHPC formulations within normal epithelium,dysplastic tissue,and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model[J]. Lasers Surg Med, 2013,45(10):668-678.
[16] Chu M,Su YX,Wang L,et al. Myeloid-derived suppressor cells contribute to oral cancer progression in 4NQO-treated mice[J]. Oral Dis, 2012,18(1):67-73.
[17] Yang Z,Guan B,Men T,et al. Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer,associated with poor prognosis of patients[J]. In Vivo, 2013,27(4):473-484.
[18] Nunoshiba T,Demple B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide[J]. Cancer Res,1993, 53(14):3250-3252.
[19] Booth DR. A relationship found between intra-oral sites of 4NQO reductase activity and chemical carcinogenesis[J]. Cell Tissue Kinet, 1990,23(4):331-340.
[20] Kitano M,Hatano H,Shisa H. Strain difference of susceptibility to 4-nitroquinoline-1-oxide-induced togue carcinoma in rats[J]. Jpn J Cancer Res,1992,83(8):843-850.
[21] Tanuma JI,Fujii K,Hiirano M,et al. Five quantitative traint loci affecting 4-nitroquinoline-1-oxide indeced tongue cancer in the rat[J]. Jpn J Cancer Res,2001,92(6):610-616.
[22] Darroudi F,Natarajan AT,Lohman PH. Cytogenetical characterization of UV-sensitive repair-deficient CHO cell line 43-3B II induction of cell killing,chromosomal aberrations and sister-chromatid exchanges by 4NQO,mono- and bi-functional alkylating agents[J]. Mutat Res,1989,212(2):103-112.
[23] Bosselaers IE,Caessens PW,Van Boekel MA,et al. Differential effects of milk proteins,BSA and soy protein on 4NQO-or MNNG-induced SCEs in V79 cells[J]. Food Chem Toxicol,1994,32(10):905-909.
[24] Kim MM,Glazer CA,Mambo E,et al. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO[J]. Oral Oncol,2006,42(2):201-207.
[25] 陈慧,高鑫,李刚,等. 4NQO诱发C57BL/6小鼠舌癌及食管鳞状细胞癌模型的建立[J]. 苏州大学学报:医学版,2010,30(5):972-974.
[26] 李晶,于大海,卿海云,等. 4-硝基喹啉-1-氧化物饮水法构建BALB/C小鼠胃癌及食管癌模型[J]. 中华实验外科杂志,2011, 28(9):1411.
[27] 杜展,王超,张勇,等. C57BL/6小鼠食管鳞状细胞癌早期病变的形态学改变[J]. 世界华人消化杂志,2013,21(2):116-121.
[28] Tang XH,Knudsen B,Bemis D,et al. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice[J]. Clin Cancer Res,2004,10(1):301-303.
[29] Gunji A,Uemura A,Tsutsumi M,et al. Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide,a carcinogen producing bulky adducts[J]. Cancer Lett,2006,241(1):87-92.
[30] Wilkey JF,Buchberger G,Saucier K,et al. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium[J]. Mol Carcinog, 2009,48(9):853-861.
[31] 黄裔腾,殷秀凯,钟雪云,等. 食管鳞癌动物模型的研究进展[J]. 世界华人消化杂志,2011,19(16):1704-1710. |
